EFFICACY OF INTRA-ARTERIAL LIDOCAINE FOR PAIN CONTROL RESULTING FROM TRANSARTERIAL CHEMOEMBOLIZATION OF HEPATOCELLULAR CARCINOMA

EFFICACY OF INTRA-ARTERIAL LIDOCAINE FOR PAIN CONTROL RESULTING FROM TRANSARTERIAL CHEMOEMBOLIZATION OF HEPATOCELLULAR CARCINOMA

Objective: To assess the efficacy of intra-arterial lidocaine in peri & post-procedural pain control and the dose of narcotic analgesic required in hepatocellular carcinoma patients undergoing transarterial chemoembolization. Study Design: Comparative prospective study. Place and Duration...

Full description

Bibliographic Details
Main Authors:	Ghulam Abbas, Atif Sheraz, Raza Rahim
Format:	Article
Language:	English
Published:	Army Medical College Rawalpindi 2021-06-01
Series:	Pakistan Armed Forces Medical Journal
Subjects:	hepatocellular carcinoma (hcc) intra-arterial lidocaine pain control and pes (post embolization syndrome) trans arterial chemoembolization (tace) & visual analogue score (vas)
Online Access:	https://pafmj.org/index.php/PAFMJ/article/view/4843

Similar Items

Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy
by: Jang JH, et al.
Published: (2015-09-01)

Transcatheter administration of buffered Lidocaine for pain relief due to transarterial chemoembolization for HCC
by: Mohammad Alaa Abusedera, et al.
Published: (2014-06-01)

Early experience of combination therapy of transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma measuring 3–7 cm
by: Yashwant Patidar, et al.
Published: (2019-01-01)

Evaluation of patients undergoing Transarterial Chemoembolization (TACE) for Hepatocellular Carcinoma with respect to tumor size, site and number of lesions
by: Amjad Sattar, et al.
Published: (2013-12-01)

Adjuvant transarterial chemoembolization timing after radical resection is an independent prognostic factor for patients with hepatocellular carcinoma
by: Hongfa Sun, et al.
Published: (2023-03-01)

Prognostic factors and an innovative nomogram model for patients with hepatocellular carcinoma treated with postoperative adjuvant transarterial chemoembolization
by: Jing-Xuan Xu, et al.
Published: (2023-12-01)

Transcatheter Arterial Chemoembolization with Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma: Recommended Selection for Small-Caliber (<100 μm) Beads
by: Chang WC, et al.
Published: (2021-08-01)

Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A systematic review and meta-analysis
by: Jun-Ning Liu, et al.
Published: (2023-02-01)

Secondary Polycythemia in Hepatocellular Carcinoma: Treat or No Treat
by: Poernomo Budi Setiawan, et al.
Published: (2020-07-01)

Transarterial Chemoembolization in Hepatocellular Carcinoma, Albanian Experience.
by: Ilirian Laçi, et al.
Published: (2022-07-01)

Corrigendum: Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: a systematic review and meta-analysis
by: Jun-Ning Liu, et al.
Published: (2023-06-01)

Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
by: Yi-Sheng Liu, et al.
Published: (2018-08-01)

Transradial approach for transarterial chemoembolization of hepatocellular carcinoma in Egyptian patients: Initial study
by: Mohamed El-Gharib, et al.
Published: (2016-09-01)

A review of applying transarterial chemoembolization (TACE) method for management of hepatocellular carcinoma
by: Hossein Ghanaati, et al.
Published: (2021-01-01)

Effect of prophylactic transcatheter arterial chemoembolization on hepatocellular carcinoma with microvascular invasion after R0 resection. A case-control study
by: Ke-Yue Li, et al.
Published: (2020-04-01)

Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review
by: Sacco R, et al.
Published: (2017-07-01)

Intra-arterial chemoembolization with hepasphere 50–100 μm for patients with unresectable hepatocellular
by: Talal Amer, et al.
Published: (2015-12-01)

TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION IN THE TREATMENT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA ON ADVANCED LIVER CIRRHOSIS
by: A. S. Polekhin, et al.
Published: (2020-03-01)

Construction of a prognostic model for hepatocellular carcinoma patients receiving transarterial chemoembolization treatment based on the Tumor Burden Score
by: Jiawei Lin, et al.
Published: (2024-03-01)

Longitudinal Analysis of the Effect of Repeated Transarterial Chemoembolization for Liver Cancer on Portal Venous Pressure
by: Constantine Frangakis, et al.
Published: (2021-11-01)

Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial
by: Liang-Cheng Chen, et al.
Published: (2019-03-01)

Transarterial Chemoembolization of Hepatocellular Carcinoma with Idarubicin-Loaded Tandem Drug-Eluting Embolics
by: Boris Guiu, et al.
Published: (2019-07-01)

Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma
by: Yehyun Park, et al.
Published: (2019-04-01)

Combination of Sorafenib and Transarterial Chemoembolization in Selected Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study at Three German Liver Centers
by: Christine Koch, et al.
Published: (2021-04-01)

Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysis
by: Rong Cai, et al.
Published: (2017-11-01)

The Role of Immediate Post-Procedural Cone-Beam Computed Tomography (CBCT) in Predicting the Early Radiologic Response of Hepatocellular Carcinoma (HCC) Nodules to Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE)
by: Marco Fronda, et al.
Published: (2022-11-01)

Trans-Arterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: A Single Tertiary Care Institute Experience
by: Parvez Ahmed, et al.
Published: (2023-07-01)

A Rare Complication Following Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Wei-Chen Lin, et al.
Published: (2015-12-01)

PNI-Based Nomograms to Predict Tumor Progression and Survival for Patients with Unresectable Hepatocellular Carcinoma Undergoing Transcatheter Arterial Chemoembolization
by: Kai Lei, et al.
Published: (2023-01-01)

Both anti-angiogenesis and immunotherapy combined with interventional therapy in treatment of hepatocellular carcinoma: effect of hepatic artery infusion chemotherapy compared with hepatic artery chemoembolization
by: ZHANG Xihao, ZHANG Xinyun, CAO Manqing, ZHANG Jinliang, WANG Huaqi, ZHANG Su, FU Zhou, WANG Lu, ZHANG Ti
Published: (2022-05-01)

Conversion Therapy of Large Unresectable Hepatocellular Carcinoma With Ipsilateral Portal Vein Tumor Thrombus Using Portal Vein Embolization Plus Transcatheter Arterial Chemoembolization
by: Chengjian He, et al.
Published: (2022-06-01)

Comparison of Treatment Response, Survival Profiles, as Well as Safety Profiles Between CalliSpheres® Microsphere Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Huge Hepatocellular Carcinoma
by: Xuhua Duan, et al.
Published: (2022-01-01)

Initial Transarterial Chemoembolization (TACE) Using HepaSpheres 20–40 µm and Subsequent Lipiodol TACE in Patients with Hepatocellular Carcinoma > 5 cm
by: Su Min Cho, et al.
Published: (2021-04-01)

Intraarterial Lidocaine Administration for Pain Control by Water-in-Oil Technique in Transarterial Chemoembolization: in vivo and Randomized Clinical Trial
by: Wang LZ, et al.
Published: (2021-10-01)

Prognostic value of systemic immune-inflammation index/ albumin for transcatheter arterial chemoembolization treatment
by: Yali Tian, et al.
Published: (2023-04-01)

Balloon-Occluded Transarterial Chemoembolization: In Which Size Range Does It Perform Best? A Comparison of Its Efficacy versus Conventional Transarterial Chemoembolization, Using Propensity Score Matching
by: Rita Golfieri, et al.
Published: (2021-07-01)

Prognostic Comparison Between Liver Resection and Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Patients With Bile Duct Tumor Thrombus: A Propensity-Score Matching Analysis
by: Zong-Han Liu, et al.
Published: (2022-03-01)

Transarterial chemoembolization for hepatocellular carcinoma in Fontan surgery patient
by: Antonio Orlacchio, M.D., et al.
Published: (2020-12-01)

Association of TIM-3 with BCLC Stage, Serum PD-L1 Detection, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
by: Maria Tampaki, et al.
Published: (2020-01-01)

Retrospective Analysis of the Effect of Lidocaine Combined with Methylprednisolone on Pain Control After Uterine Artery Embolization
by: Yi Tang, et al.
Published: (2022-04-01)